Anti-CCDC59 monoclonal antibody

Pre-made anti-CCDC59 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CCDC59/CCDC59 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2411-Ab-1/ GM-Tg-hg-IP2411-Ab-2Anti-Human CCDC59 monoclonal antibodyHuman
GM-Tg-rg-IP2411-Ab-1/ GM-Tg-rg-IP2411-Ab-2Anti-Rat CCDC59 monoclonal antibodyRat
GM-Tg-mg-IP2411-Ab-1/ GM-Tg-mg-IP2411-Ab-2Anti-Mouse CCDC59 monoclonal antibodyMouse
GM-Tg-cynog-IP2411-Ab-1/ GM-Tg-cynog-IP2411-Ab-2Anti-Cynomolgus/ Rhesus macaque CCDC59 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2411-Ab-1/ GM-Tg-felg-IP2411-Ab-2Anti-Feline CCDC59 monoclonal antibodyFeline
GM-Tg-cang-IP2411-Ab-1/ GM-Tg-cang-IP2411-Ab-2Anti-Canine CCDC59 monoclonal antibodyCanine
GM-Tg-bovg-IP2411-Ab-1/ GM-Tg-bovg-IP2411-Ab-2Anti-Bovine CCDC59 monoclonal antibodyBovine
GM-Tg-equg-IP2411-Ab-1/ GM-Tg-equg-IP2411-Ab-2Anti-Equine CCDC59 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2411-Ab-1/ GM-Tg-hg-IP2411-Ab-2; GM-Tg-rg-IP2411-Ab-1/ GM-Tg-rg-IP2411-Ab-2;
GM-Tg-mg-IP2411-Ab-1/ GM-Tg-mg-IP2411-Ab-2; GM-Tg-cynog-IP2411-Ab-1/ GM-Tg-cynog-IP2411-Ab-2;
GM-Tg-felg-IP2411-Ab-1/ GM-Tg-felg-IP2411-Ab-2; GM-Tg-cang-IP2411-Ab-1/ GM-Tg-cang-IP2411-Ab-2;
GM-Tg-bovg-IP2411-Ab-1/ GM-Tg-bovg-IP2411-Ab-2; GM-Tg-equg-IP2411-Ab-1/ GM-Tg-equg-IP2411-Ab-2
Products NameAnti-CCDC59 monoclonal antibody
Formatmab
Target NameCCDC59
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CCDC59 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2411-Ag-1Recombinant multi-species TAP26/ CCDC59/ BR22 protein


    Target information

    Target IDGM-IP2411
    Target NameCCDC59
    Gene ID29080,52713,314799,698443,611585,101093619,615189,100061266
    Gene Symbol and Synonyms2300004H16Rik,BR22,CCDC59,D10Ertd718e,HSPC128,RGD1311912,TAP26
    Uniprot AccessionQ9P031,A5PJN1
    Uniprot Entry NameTAP26_HUMAN,TAP26_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000133773
    Target ClassificationN/A

    The target: CCDC59, gene name: CCDC59, also named as BR22, HSPC128, TAP26. Enables RNA binding activity. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.